ANF INNOVATIONS PTY LTD

Rifabutin

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  4-N-ISOBUTYLSPIROPIPERIDYLRIFAMYCIN S;RIFABUTINE;1,4-dihydro-1-deoxy-1��,4-didehydro-5��-(2-methylpropyl)-1-oxo-rifamycinxi;1,4-dihydro-1-deoxy-1��,4-didehydro-5��-(2-methylpropyl)-1-oxorifamycinxiv;1��,4-Didehydro-1-deoxy-1,4-dihydro-5��-(2-methylpropyl)-1-oxo-;4-deoxo-3,4-(2-spiro(n-isobutyl-4-piperidyl)-2,5-dihydro-1h-imidazo)-rifamyc;Ansamycin;(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl acetate;

• CAS NO :

  72559-06-9

• EC NO :

• Molecular Formula :

  C₄₆H₆₂N₄O₁₁

• Molecular Weight :

  847.0047

• Main Specifications :

• InChI :

  InChI=1/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1

• Molecular Structure :